Title: Clinical Effect of Herba Erigerontis Breviscapi Combined with Low Molecular Heparin on Nephrotic Syndrome
Abstract: Objective To explore the clinical effect of Herba Erigerontis Breviscapi combined with low molecular heparin on nephrotic syndrome.Methods We performed a retrospective analysis on the clinical data of 78 patients with primary nephrotic syndrome patients in our hospital from January 2009 to December 2010.The patients were randomly divided into two groups: treatment group and control group,with 39 cases in each group.Patients in the control group were given conventional treatment.Patients in the treatment group were given Herba Erigerontis Breviscapi combined with low molecular heparin besides conventional treatment.The treatment period lasted for about two weeks.The levels of urine protein,serum triglyceride(TG),total cholesterol(Chol),serum albumin(ALB)and activation of blood coagulation enzyme time(APTT),fibrinogen(FIB)of patients in two groups were tested and the clinical effect was compared between two groups.Results The curative effect of the treatment group was better than the control group,with the effective rate of 92.3% and 71.8%(P0.05).Compared with the control group,the treatment group,there was a signinicant increase of 24 h urine protein,and a significant increase of serum albumin,serum triglyceride and total cholesterol in patients in treatment group.The active site blood coagulation time was significantly longer and the fibrinogen(FIB)was reduced in treatment group than control group.Conclusion Herba Erigerontis Breviscapi combined with low molecular heparin can improve the levels of urinary albumin,decrease the blood lipids levels,improve the high coagulative state and improve the serum albumin levels of primary nephrotic syndrome patients,so has good therapeutic effect.
Publication Year: 2012
Publication Date: 2012-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot